Literature DB >> 22535496

Association of MicroRNA-146a with autoimmune diseases.

Wang-Dong Xu1, Man-Man Lu, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

MicroRNAs (miRNAs) are a group of approximately 20-22-nucleotide-long non-coding RNAs that repress target gene expression through mRNA degradation and translation inhibition. MiRNA (miR)-146a, located in the second exon of the LOC285628 gene on human chromosome 5, is a negative regulator in immune and inflammatory responses. Studies have indicated that miR-146a is associated with the pathogenesis of several autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome. In this review, emphasis will be laid on the recent progress in the functional roles of miR-146a in these autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22535496     DOI: 10.1007/s10753-012-9467-0

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  44 in total

1.  Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis.

Authors:  Jianxin Lu; Bonnie Ching-Ha Kwan; Fernand Mac-Moune Lai; Lai-Shan Tam; Edmund Kwok-Ming Li; Kai-Ming Chow; Gang Wang; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Nephrology (Carlton)       Date:  2012-05       Impact factor: 2.506

2.  Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome.

Authors:  Erika Zilahi; Tünde Tarr; Gábor Papp; Zoltán Griger; Sándor Sipka; Margit Zeher
Journal:  Immunol Lett       Date:  2011-10-20       Impact factor: 3.685

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

4.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritis.

Authors:  Tomoyuki Nakasa; Hayatoshi Shibuya; Yoshihiko Nagata; Takuya Niimoto; Mitsuo Ochi
Journal:  Arthritis Rheum       Date:  2011-06

6.  Salivary gland cytokine expression in NOD and normal BALB/c mice.

Authors:  S Yamano; J C Atkinson; B J Baum; P C Fox
Journal:  Clin Immunol       Date:  1999-09       Impact factor: 3.969

7.  Relationship between serum levels of IL-18 and IgG1 in patients with primary Sjögren's syndrome, rheumatoid arthritis and healthy controls.

Authors:  P Eriksson; C Andersson; C Ekerfelt; J Ernerudh; T Skogh
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

8.  Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  Jingyi Li; Ying Wan; Qiuye Guo; Liyun Zou; Jinyu Zhang; Yongfei Fang; Jingbo Zhang; Jinjun Zhang; Xiaolan Fu; Hongli Liu; Liwei Lu; Yuzhang Wu
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

9.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

10.  A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.

Authors:  Xiaobing Luo; Wanling Yang; Dong-Qing Ye; Huijuan Cui; Yan Zhang; Nattiya Hirankarn; Xiaoxia Qian; Yuanjia Tang; Yu Lung Lau; Niek de Vries; Paul Peter Tak; Betty P Tsao; Nan Shen
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

View more
  31 in total

1.  Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.

Authors:  Cristen B Chafin; Nicole L Regna; Sarah E Hammond; Christopher M Reilly
Journal:  Int Immunopharmacol       Date:  2013-10-09       Impact factor: 4.932

Review 2.  The association between susceptibility to inflammatory arthritis and miR-146a, miR-499 and IRAK1 polymorphisms. A meta-analysis.

Authors:  G G Song; S-C Bae; Y H Seo; J-H Kim; S J Choi; J D Ji; Y H Lee
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

3.  MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Authors:  M H Albert; J Mannert; K K Fleischmann; M Schiemann; P Pagel; I Schmid; T Magg
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

4.  Association between IRAK1 rs3027898 and miRNA-499 rs3746444 polymorphisms and rheumatoid arthritis : A case control study and meta-analysis.

Authors:  X-K Yang; P Li; C Zhang; R-X Leng; S Li; J Liu; B-Z Li; H-F Pan; D-Q Ye
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 5.  The miR-146a polymorphism and susceptibility to systemic lupus erythematosus and rheumatoid arthritis : a meta-analysis.

Authors:  Y H Lee; S-C Bae
Journal:  Z Rheumatol       Date:  2015-03       Impact factor: 1.372

6.  miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity.

Authors:  Bo Li; Xi Wang; In Young Choi; Yu-Chen Wang; Siyuan Liu; Alexander T Pham; Heesung Moon; Drake J Smith; Dinesh S Rao; Mark P Boldin; Lili Yang
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

7.  Association of miR-146a rs2910164 with childhood IgA nephropathy.

Authors:  Junhong Lin; Yao Huang; Xuelin Zhang; Junbin Chen; Haihui Sheng
Journal:  Pediatr Nephrol       Date:  2014-04-30       Impact factor: 3.714

8.  Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).

Authors:  Lia Furlaneto Marega; Marcelo Ananias Teocchi; Maria Marluce Dos Santos Vilela
Journal:  Clin Exp Immunol       Date:  2016-05-24       Impact factor: 4.330

9.  The shaping and functional consequences of the microRNA landscape in breast cancer.

Authors:  Heidi Dvinge; Anna Git; Stefan Gräf; Mali Salmon-Divon; Christina Curtis; Andrea Sottoriva; Yongjun Zhao; Martin Hirst; Javier Armisen; Eric A Miska; Suet-Feung Chin; Elena Provenzano; Gulisa Turashvili; Andrew Green; Ian Ellis; Sam Aparicio; Carlos Caldas
Journal:  Nature       Date:  2013-05-05       Impact factor: 49.962

10.  Relationship of miRNA-146a to primary Sjögren's syndrome and to systemic lupus erythematosus: a meta-analysis.

Authors:  Hong-Yan Sun; An-Kun Lv; Hua Yao
Journal:  Rheumatol Int       Date:  2017-06-01       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.